What Researchers Did
Researchers conducted a single-center, randomized controlled trial comparing hyperbaric oxygen therapy (HBOT) to a sham control or waitlist in adults 6 to 36 months post-ischemic stroke.
What They Found
The abstract provided did not include the study's findings, therefore specific numbers regarding the primary and secondary outcomes cannot be reported. The study aimed to detect a clinically important difference of 10 on the SIS-16 score with a target sample size of 68 participants per arm, but only 34 participants were enrolled.
What This Means for Canadian Patients
Without the study's findings, it is not possible to determine the practical implications of hyperbaric oxygen therapy for Canadian stroke patients. Further research with complete results is needed to assess its potential benefits or risks.
Canadian Relevance
This study was conducted at the Vancouver General Hospital Hyperbaric Unit, making it directly relevant to healthcare practices and research infrastructure in Canada.
Study Limitations
The study faced recruitment challenges, resulting in an altered control arm from a sham to a waitlist, and the abstract provided is incomplete.